Tag: Drug Pricing

Something Happened to U.S. Drug Costs in the 1990s | The New York Times

Something Happened to U.S. Drug Costs in the 1990s | The New York Times

Another potential explanation is that Americans take more expensive brand-name drugs than cheaper generics relative to their overseas counterparts. This doesn’t hold up either. We use a greater proportion of generic drugs here than most other countries — 84 percent of prescriptions are generic. Though Americans take a lower proportion of brand-name drugs, the prices […]

Congress should broaden legislation to curb medical price gouging | TheHill

Congress should broaden legislation to curb medical price gouging | TheHill

Washington is taking notice of an important problem: hospital price gouging of unsuspecting patients. The No More Surprise Medical Bills Act of 2018, introduced last month by Democratic Sens. Maggie Hassan and Jeanne Shaheen of New Hampshire, followed a bill offered earlier this year by six senators, the bipartisan Protecting Patients from Surprise Medical Bills […]

Dem overtures to Trump on drug pricing worry pharma | TheHill

Dem overtures to Trump on drug pricing worry pharma | TheHill

The Democratic takeover of the House is giving new life to efforts to fight high drug prices with bipartisan action, a worrying prospect for the pharmaceutical industry. It’s a top priority for House Democrats, who now have powers to press the issue and put the drug industry on the hot seat. It’s also an issue […]

Split Congress to Attack Drug Pricing | Pharmaceutical Executive

Split Congress to Attack Drug Pricing | Pharmaceutical Executive

Healthcare was the deciding issue for more than 40 percent of voters in the mid-term elections, setting the stage for action on Capitol Hill to further challenge too-high prescription drug prices. Concerns over access to affordable care helped Democrats take control of the House. And even though Republicans increased their majority in the Senate, they […]

Tale of 2 CEOs: Merck chief treads carefully on pricing, while Pfizer’s Read predicts more hikes | FiercePharma

Tale of 2 CEOs: Merck chief treads carefully on pricing, while Pfizer’s Read predicts more hikes | FiercePharma

Two Big Pharma CEOs have sounded off on drug pricing, and what a difference between the two. Merck’s Ken Frazier stayed in safe territory with his barbs against rebates, but Pfizer’s Ian Read touched off controversy by predicting a return to price hikes. During separate sets of remarks this week, Frazier took a line that’s […]

Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure | Reuters

Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure | Reuters

COPENHAGEN (Reuters) – Novo Nordisk (NOVOb.CO), the world’s top maker of diabetes drugs, reported encouraging sales of its main growth drivers on Thursday as it announced more job cuts amid a restructuring to cope with intensifying pricing pressure in the United States. The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the […]

Merck CEO on US healthcare system and drug pricing [Video] | CNBC

Merck CEO on US healthcare system and drug pricing [Video] | CNBC

Merck CEO Ken Frazier discusses the U.S. healthcare system and President Donald Trump’s drug pricing plan. Read complete article here: Merck CEO on US healthcare system and drug pricing.

Prescription Drug Prices: A Bitter Pill In The Midterm Elections | Forbes

Prescription Drug Prices: A Bitter Pill In The Midterm Elections | Forbes

All the campaign rhetoric leading up to Election Day 2018 next Tuesday is enough to give you a headache. Maybe that’s one reason why high prescription drug prices have become a major concern among older voters for the midterm elections. “This is a pain point,” said Tim Lash, chief strategy officer of West Health Institute […]

Prices vary within hospitals: Why patients should price shop payers | Becker’s Hospital Review

Prices vary within hospitals: Why patients should price shop payers | Becker’s Hospital Review

Research on price variation in healthcare often shows the stark differences patients pay for the same procedure at one hospital compared to another. However, a working paper published by the National Bureau of Economic Research suggests payers play an equally significant role in price variation, even within the same hospital. … For these five procedures, […]

Answering Your Questions about the IPI Drug Pricing Model | HHS

Answering Your Questions about the IPI Drug Pricing Model | HHS

How will this model affect patient access? Could this change my Medicare benefits? The IPI model does not include any restrictions on patient access or choice of drugs. This stands in marked contrast to proposals that would impose formularies in order to negotiate down drug prices. Given the size of the U.S. drug market and […]